$1.123
+0.089 (+7.95%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
BioStem Technologies, Inc. (BSEM) Moving Averages Convergence Divergence (MACD) indicator is -0.49, suggesting BSEM is Strong sell.
BioStem Technologies, Inc. (BSEM) 20-Day simple moving average is 1.58, while BioStem Technologies, Inc. (BSEM) share price is $—, making it Sell.
BioStem Technologies, Inc. (BSEM) 60-Day simple moving average is 2.94, while BioStem Technologies, Inc. (BSEM) share price is $—, making it Sell.
Technical Analysis for BSEM
AI Technical BSEMAs of 2026-11-07, the technical board for BioStem Technologies, Inc. (BSEM) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $1.12 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 26.092, MACD stands at -0.492 (Sell), Stochastic %K stands at 9.414 (Buy), Stochastic %D stands at 8.052 and CCI stands at -102.869 (Buy).
BSEM trades below the 60-day SMA (2.94) and below the 200-day SMA (4.11). Immediate resistance sits at Classic R1 1.58, then R2 1.91. Support sits at Classic S1 0.97, then S2 0.69.
BioStem Technologies, Inc. (BSEM) Support & Resistance Level
BioStem Technologies, Inc. (BSEM) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 26.092 |
| STOCHk_14_3_3 | 9.414 |
| STOCHd_14_3_3 | 8.052 |
| CCI_20 | -102.869 |
| AO_5_34 | -1.183 |
| MOM_10 | -0.440 |
| MACD_12_26_9 | -0.492 |
BioStem Technologies, Inc. (BSEM) Relative Strength Index (RSI_14) is 26.092, creating a Buy signal.
BioStem Technologies, Inc. (BSEM) Stochastic %K is 9.414, creating a Buy signal.
BioStem Technologies, Inc. (BSEM) Stochastic %D is 8.052, creating a Buy signal.
BioStem Technologies, Inc. (BSEM) CCI_20 is -102.869, creating a Buy signal.
BioStem Technologies, Inc. (BSEM) Awesome Oscillator (AO) is -1.183, creating a Sell signal.
BioStem Technologies, Inc. (BSEM) Momentum (MOM) is -0.440, creating a Sell signal.
BioStem Technologies, Inc. (BSEM) Moving Average Convergence Divergence (MACD) is -0.492, creating a Sell signal.
BioStem Technologies, Inc. (BSEM) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.125 | Sell |
| MA_10 | 1.256 | Sell |
| MA_20 | 1.579 | Sell |
| MA_60 | 2.935 | Sell |
| MA_200 | 4.111 | Sell |
| MA_250 | 4.139 | Sell |
BioStem Technologies, Inc. (BSEM) 5-Day simple moving average is 1.125, while BioStem Technologies, Inc. (BSEM) share price is $, making it a Sell.
BioStem Technologies, Inc. (BSEM) 10-Day simple moving average is 1.256, while BioStem Technologies, Inc. (BSEM) share price is $, making it a Sell.
BioStem Technologies, Inc. (BSEM) 20-Day simple moving average is 1.579, while BioStem Technologies, Inc. (BSEM) share price is $, making it a Sell.
BioStem Technologies, Inc. (BSEM) 60-Day simple moving average is 2.935, while BioStem Technologies, Inc. (BSEM) share price is $, making it a Sell.
BioStem Technologies, Inc. (BSEM) 200-Day simple moving average is 4.111, while BioStem Technologies, Inc. (BSEM) share price is $, making it a Sell.
BioStem Technologies, Inc. (BSEM) 250-Day simple moving average is 4.139, while BioStem Technologies, Inc. (BSEM) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.